Hikma Pharmaceutical reported $23M in Cash and Equivalent for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Artemis Alpha ATS:LN GBP 2.39M 4.76M
AstraZeneca AZN:LN USD 4.46B 359M
Bayer BAYN:GR EUR 4.36B 949M
Fresenius FRE:GR EUR 2.13B 1000K
Fresenius Medical Care FMS:US EUR 1.11B 88.88M
Genmab GEN:DC DKK 10.38B 561M
GlaxoSmithKline GSK:LN GBP 3.72B 117M
Hikma Pharmaceutical HIK:LN USD 23M 1000K
Lonza Group LONN:SW CHF 1.34B 187M
Merck MRK:GR EUR 1.6B 24M
Orion ORNBV:FH EUR 367.1M 281M
Recordati REC:IM EUR 346.61M 27.15M
Roche Holding ROG:VX 4.32B 2.54B